DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today reported financial results for the second quarter of 2021 and provided a corporate and commercial update.
Nemaura Medical, Inc., a medical technology company focused on developing and commercializing non-invasive wearable diagnostic devices and supporting personalized lifestyle coaching programs, today provides a business update and releases its financial results for the first fiscal quarter, ended June 30, 2021, of fiscal 2022.
Fitness platform using glucose biomarkers, Ultrahuman, has officially announced a $17.5 million Series B fundraise, with investment coming from early stage fund Alpha Wave Incubation, Steadview Capital, Nexus Venture Partners, Blume Ventures and Utsav Somani’s iSeed fund.
LifeScan and Cecelia Health, one of the nation’s most scalable virtual care companies focused on diabetes and chronic disease management, today announced the addition of a fully integrated live telehealth service with the OneTouch Reveal app.
#product & service
#telehealth
#mobile app
Mobile health (mHealth) technology that addresses diabetes mellitus in pregnancy has the potential to improve maternal and child health while diminishing socioeconomic and racial disparities. Little is known about health literacy, electronic health literacy, or patient characteristics that contribute to increased mHealth use. In this pilot study, we aimed to examine patient factors associated with user engagement with a novel app for diabetes support during pregnancy.
#mobile app
Insulet Corporation, the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced that management will present at three upcoming virtual investor conferences: i)The 2021 Virtual Wells Fargo Healthcare Conference on Thursday, September 9, 2021 at 1:20 p.m. (Eastern Time) ii)The Morgan Stanley 19th Annual Global Healthcare Conference on Friday, September 10, 2021 at 1:15 p.m. (Eastern Time) iii)The Baird 2021 Global Healthcare Conference on Wednesday, September 15, 2021 at 2:00 p.m. (Eastern Time)
Live webcasts of BD's presentations can be accessed on the BD corporate website at www.bd.com/investors. Any related materials will be posted on the BD investor relations website prior to the presentations. A replay will be available for a minimum of seven days after each conference.
Changing our name, announcing our progress, and building our vision. Today, our team is excited to bring everything we’ve done at CoachMe Health to our new name, Verano Health. We’re on the brink of launching our first partnerships with Medicaid and wrapping up Y Combinator. Our tech-enabled prevention program, Healthy at Home, delivers telehealth diabetes self-management education and medical nutrition therapy. Healthy at Home combines the coaching that inspired CoachMe with health education, daily tracking, and mental health support.
The Company update presentations will be webcast live, and an archive recording will be available for 30 days. The link to the live webcast and archive will be accessible on Tandem Diabetes Care’s Investor Center website located at http://investor.tandemdiabetes.com in the “Events & Presentations” section.
On-going manufacturer-led post-market surveillance (PMS), assessing the clinical accuracy of blood glucose monitoring (BGM) systems, is critical to substantiate the performance of such products for people with diabetes.
#bgm